October 19, 2001
The list, at http://www.atac-usa.org/RDACommittee.html (scroll down, or click on "Chart on drugs in development", has the generic or chemical name of each compound, the class of drug (nucleoside analog, protease inhibitor, etc.), the phase of development (preclinical, phase I, phase II, phase III, or approved), and the pharmaceutical company doing the work.
For another extensive list of drugs in (or formerly in) development, see the Treatment Action Group (TAG) article: "Coming, Going and Gone: The Drug Development Pipeline, 2002."
For more information about some of the more prominent new drugs currently being researched, see "New Agents for Anti-HIV Therapy," by Joseph J. Eron Jr., M.D., and Robert L. Murphy, M.D. It is available on the Medscape site, http://hiv.medscape.com (click on "New Agents for Anti-HIV Therapy" if this link is still there, or search the site for the author's last name, and look for the title in the results returned). Note: The Medscape site requires registration, but registration is free, and it need be done only once (provided you remember the user ID and password you choose). Most articles on continuing-education medical sites remain online for one year.
Copyright 2001 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.
ISSN # 1052-4207
Back to the AIDS Treatment News October 19, 2001 contents page.